A new study released today by the Biotechnology Industry Organization, a biotechnology-industry trade group known as BIO, estimates that licensing deals for university-developed inventions contributed $47-billion to $182-billion cumulatively to the U.S. gross domestic product from 1996 through 2007. In a separate survey by BIO of 150 biotechnology companies, also released today, a majority said they depended heavily on licenses with universities, particularly because those institutions are less restrictive than federal agencies in their willingness to grant exclusive licenses.
|
Previous |
Next Pfizer Is Ordered to Pay $850,000 to Brigham Young U. for Delaying Patent Litigation |
2 Reports Highlight Value of University Licenses to Biotech Industry
October 28, 2009, 6:12 pm
Confirm Your Email Address
You must confirm the email address associated with your account to use this Chronicle feature.
If you have already confirmed your account, try refreshing your browser.
E-mail a Friend

